| FR3D: finding local and composite recurrent structural motifs in RNA 3D structures M Sarver, CL Zirbel, J Stombaugh, A Mokdad, NB Leontis Journal of mathematical biology 56 (1), 215-252, 2008 | 363 | 2008 |
| Unique tertiary and neighbor interactions determine conservation patterns of Cis Watson–Crick A/G base-pairs J Šponer, A Mokdad, JE Šponer, N Špačková, J Leszczynski, NB Leontis Journal of molecular biology 330 (5), 967-978, 2003 | 82 | 2003 |
| Structural and evolutionary classification of G/U wobble basepairs in the ribosome A Mokdad, MV Krasovska, J Sponer, NB Leontis Nucleic Acids Research 34 (5), 1326-1341, 2006 | 71 | 2006 |
| Leading RNA tertiary interactions: structures, energies, and water insertion of A-minor and P-interactions. A quantum chemical view JE Šponer, K Reblova, A Mokdad, V Sychrovský, J Leszczynski, J Šponer The Journal of Physical Chemistry B 111 (30), 9153-9164, 2007 | 45 | 2007 |
| Elastic properties of ribosomal RNA building blocks: molecular dynamics of the GTPase-associated center rRNA F Razga, J Koča, A Mokdad, J Šponer Nucleic acids research 35 (12), 4007-4017, 2007 | 36 | 2007 |
| Ribostral: an RNA 3D alignment analyzer and viewer based on basepair isostericities A Mokdad, NB Leontis Bioinformatics 22 (17), 2168-2170, 2006 | 23 | 2006 |
| A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors M Escobar, M Bullano, AG Mokdad, J Caicedo, BG Schultz, Q Fan, ... Expert Review of Hematology 16 (6), 467-474, 2023 | 15 | 2023 |
| Molecular basis of TRAP–5′ SL RNA interaction in the Bacillus subtilis trp operon transcription attenuation mechanism AP McGraw, A Mokdad, F Major, PC Bevilacqua, P Babitzke RNA 15 (1), 55-66, 2009 | 13 | 2009 |
| ISFOLD: structure prediction of base pairs in non-helical RNA motifs from isostericity signatures in their sequence alignments A Mokdad, AD Frankel Journal of Biomolecular Structure and Dynamics 25 (5), 467-472, 2008 | 12 | 2008 |
| Effects of PK‐guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A G Young, MU Callaghan, V Balasa, A Soni, S Ahuja, JC Roberts, ... Haemophilia 29 (5), 1234-1242, 2023 | 4 | 2023 |
| Review of potential barriers to effective hemostatic management of acquired hemophilia A by non-hemophilia experts in the United States A Sharathkumar, AG Mokdad Cureus 15 (1), 2023 | 3 | 2023 |
| Clinical Outcomes of Noninhibitor Patients with Hemophilia a Switching from Prophylaxis with Factor VIII to Emicizumab: A Meta-Analysis of Real-World Evidence Studies MA Escobar, QA Fan, AG Mokdad, MD Tarantino, B Burgess, E Hawe, ... Blood 142, 283, 2023 | 2 | 2023 |
| Risk of Intracranial Hemorrhage in Persons with Hemophilia A in the United States: Real-World Retrospective Cohort Study Using the ATHNdataset J Hu, M Chandler, CM Manuel, J Caicedo, M Denne, B Ewenstein, ... Journal of Blood Medicine, 191-205, 2024 | 1 | 2024 |
| Clinical outcomes in patients with haemophilia A after switching to rurioctocog alfa pegol prophylaxis in the ATHN 2 study J Journeycake, J Caicedo, D Cheng, M Denne, C Guelcher, S Lattimore, ... Haemophilia 27, 55-56, 2021 | 1 | 2021 |
| Developing Tools for RNA Structural Alignment AG Mokdad Bowling Green State University, 2006 | 1 | 2006 |
| Recombinant von willebrand factor for perioperative management of bleeding in pediatric patients with severe von willebrand disease: Interim results from a phase 3 multicenter … S Bergmann, B Zulfikar, J Meznarich, E Mullins, M Wang, S Crary, ... Blood 146, 1304, 2025 | | 2025 |
| HTRS2025. P1. 16 Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis with Recombinant Von Willebrand Factor in Children … C Marquez-Gomez, M Waliullah, Y Wang, A Mokdad, J Zhang Research and Practice in Thrombosis and Haemostasis 9, 2025 | | 2025 |
| A Phase 3, Prospective, Open-Label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis with Recombinant Von Willebrand Factor in Children Diagnosed with … C Marquez-Gomez, M Waliullah, Y Wang, AG Mokdad, J Zhang Blood 144, 5496, 2024 | | 2024 |
| Budget Impact of Factor VIII Treatments for Hemophilia A in the United States Q Fan, JA Carter, AG Mokdad, J Caicedo, M Bullano Value in Health 27 (6), S73-S73, 2024 | | 2024 |
| Identifying Ideal Individuals for PK-Guided Dosing; Recreational Risks and Elevated Breakthrough Bleeding G Young, VV Balasa, JC Roberts, A Frick, AG Mokdad, J Caicedo Blood 142, 3742, 2023 | | 2023 |
